Under the terms of the agreement, which was executed on February 9th, 2021, the companies will jointly conduct a Phase I Clinical Study of BVX-0918A in Spain, BioVaxys’ autologous haptenized protein vaccine for late-stage ovarian cancer…
SOCIAL HEADQUARTER
Avda. Miguel Hernández 21, Bajo
46450 Benifaio (Valencia – Spain)
BUSINESS HEADQUARTER
Paseo del Ferrocarril, 339 08860 Castelldefels, Barcelona +34 93 645 54 41 info@procarehealth.com
SOCIAL HEADQUARTER
Avda. Miguel Hernández 21, Bajo
46450 Benifaio (Valencia – Spain)
BUSINESS HEADQUARTER
Paseo del Ferrocarril, 339 08860 Castelldefels, Barcelona +34 93 645 54 41 info@procarehealth.com
© 2024 Procare Health
